Mechanism and clinical significance of metronidazole resistance in Helicobacter pylori

Scandinavian Journal of Gastroenterology, Supplement

Volumn 36, Issue 234, 2001, Pages 10-14

  Van Der Wouden, E J ^a   Thijs, J C ^a   Kusters, J G ^a   Van Zwet, A A ^a   Kleibeuker, J H ^a  

^a Isain Klinieken Location Sophia ^*

Author keywords

Clinical significance; Helicobacter pylori; Metronidazole resistance; rdxA

Indexed keywords

METRONIDAZOLE; ANTI INFECTIVE AGENTS; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; ELECTRON TRANSPORT; ENZYME ACTIVATION; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; RDXA GENE; SCAVENGING SYSTEM; TRICHOMONAS VAGINALIS; DRUG EFFECT; GENETICS; METABOLISM; REVIEW;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; HELICOBACTER PYLORI; HUMAN; METRONIDAZOLE;

EID: 0034746955     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273-5.
2. Pounder RE, Ng D. The prevalence of Helicobacier pylori infection in different countries. Aliment Pharmacol Ther 1995;9 Suppl 2:33-9.
3. The European Helicobacter pylori study group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 1997;41:8-13.